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I
was surprised to hear that a patient of mine, Mr. Cardosa,
had died. I had not even realized that he was hospitalized.
When his wife called, she apologized for not letting me know.
His gastric cancer had spread, and after watching him
deteriorate rapidly, Mrs. Cardosa recalled their prior discus-
sions and opted against further treatment.
She was wracked with guilt. She had felt very isolated in the
hospital and believed that the oncologist disagreed with her
decision to stop the chemotherapy. I told her that I agreed with
her, but I felt miserable about my role, or more accurately, the
absence of my role in his care.
I tried to reconstruct what had happened 10 months earlier
after I told Mr. Cardosa his diagnosis. I recalled reassuring him
and arranging for a consultation with a GI oncologist. It was
my usual practice to schedule all patients for a return visit.
But this time I did not. I reasoned that other than the cancer,
he had no active medical problems; his next several months
would be occupied with clinical issues related to his cancer.
Looking back, I believe that there were other reasons. First, I
was not comfortable in being a bystander in clinical decisions,
and second, on some level, I was relieved that someone else
would now be caring for him.
A few months later, I received a detailed consult from the
oncologist which noted his uneventful surgery and outlined
the chemotherapy protocol. I did not hear from the Cardosas
until 6 months later, when Mrs. Cardosa called to informed me
that her husband was losing weight and unable to eat. Mr.
Cardosa was emaciated and I hardly recognized him. The once
vibrant couple was despondent. Although his abdominal
computed tomography (CT) scan suggested new peritoneal
metastases, the oncologist disagreed and pushed for more
chemotherapy. I was concerned that his symptoms were
related to progressive disease, but because of my now limited
involvement with Mr. Cardosa’s care, I felt that I was in no
position to intervene.
I tried to convince myself that the oncologist should have
kept me informed, but the truth was that I had let myself slide
from participant to observer. Had I been more involved, the
Cardosas, and perhaps, even the oncologist would have
contacted me to take part in discussing the advisability of
continued chemotherapy versus palliation and hospice care.
My role in Mr. Cardosa’s care would have been different, less
central than previously, but it would still be important. The
simple gesture of suggesting return visits would have allowed
me to stay a functional part of the health care team and
perhaps spared the couple some of the isolation and suffering
they endured at the end.
Since my experiences with the Cardosas, I have begun to tell
my patients newly diagnosed with serious illnesses that
require subspecialty care (cancer, dialysis, and transplant)
that I want to see them at intervals during their treatment and
urge them to call me if they need advice. I have been struck by
how positively they respond to this recommendation. I, too, feel
better about my continued involvement with them.
My experience with the Cardosas brought into focus an
important function of the General Internist. It made me strive
to overcome concerns about status. Patients do suffer when
the General Internist is not involved. We cannot afford to
abandon our patients who develop serious illnesses even when
subspecialists assume major responsibility for their treatment.
If we do so, we deny our patients the best care; we deny
ourselves the joys and sorrows of continuity; and we fail to
fulfill our roles as General Internists.
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